CERAMENT G
-
Biologics
BoneSupport Launches Next Generation of Cerament® G
6-30-2023 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announces the launch of the…
Read More » -
Biologics
BoneSupport’s CERAMENT®G Used In First U.S. Patient Cases
10-24-2022 BONESUPPORT, an emerging leader in orthobiologics for the management of bone injuries, today announces that the company’s antibiotic-eluting bone…
Read More » -
Biologics
MCRA Assists BONESUPPORT AB with the First Ever Combination Product DeNovo Decision Granted by the U.S. FDA
CERAMENT G is the first combination product which has successfully navigated the DeNovo process.To date, MCRA has supported 5 of…
Read More » -
Biologics
BONESUPPORT – CERAMENT® G Approved by Health Canada
Lund, Sweden, 18:00 CET, 16 August 2018 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone voids,…
Read More » -
Biologics
BONESUPPORT™ Announces First Patient Enrolled in FORTIFY Trial with CERAMENT®|G
Lund, Sweden, 22 May 2017– BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone substitute products to treat bone…
Read More » -
Hospitals
BONESUPPORT™ Receives FDA Approval to Initiate IDE Clinical Study with CERAMENT™G
Lund, Sweden, 9 August – BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone substitute products to treat bone…
Read More »